QHSLab, Inc. Files 8-K Report
Ticker: USAQ · Form: 8-K · Filed: Mar 28, 2024 · CIK: 856984
Sentiment: neutral
Topics: 8-K, disclosure, filing
TL;DR
QHSLab filed an 8-K on March 28, 2024, covering disclosures and exhibits.
AI Summary
On March 28, 2024, QHSLab, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as USA EQUITIES CORP. and AMERICAN BIOGENETIC SCIENCES INC, is incorporated in Nevada and its fiscal year ends on December 31.
Why It Matters
This 8-K filing provides important updates and disclosures for QHSLab, Inc., which could impact investor understanding of the company's current status and regulatory compliance.
Risk Assessment
Risk Level: low — This filing is a routine 8-K report and does not appear to contain significant new financial information or material events that would immediately impact risk.
Key Players & Entities
- QHSLab, Inc. (company) — Registrant
- March 28, 2024 (date) — Date of earliest event reported
- USA EQUITIES CORP. (company) — Former company name
- AMERICAN BIOGENETIC SCIENCES INC (company) — Former company name
- Nevada (jurisdiction) — State of Incorporation
FAQ
What is the primary purpose of this 8-K filing for QHSLab, Inc.?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on March 28, 2024.
What are some of the former names of QHSLab, Inc. mentioned in the filing?
Some of the former names of QHSLab, Inc. mentioned in the filing include USA EQUITIES CORP. and AMERICAN BIOGENETIC SCIENCES INC.
In which state is QHSLab, Inc. incorporated?
QHSLab, Inc. is incorporated in Nevada.
What is the business address of QHSLab, Inc.?
The business address of QHSLab, Inc. is 901 Northpoint Parkway, Suite 302, West Palm Beach, FL 33407.
Filing Stats: 621 words · 2 min read · ~2 pages · Grade level 10.2 · Accepted 2024-03-28 08:00:43
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value USAQ N/A Item 7.01 Regu
Filing Documents
- form8-k.htm (8-K) — 39KB
- ex99-1.htm (EX-99.1) — 23KB
- ex99-1_001.jpg (GRAPHIC) — 5KB
- 0001493152-24-011611.txt ( ) — 240KB
- usaq-20240328.xsd (EX-101.SCH) — 3KB
- usaq-20240328_lab.xml (EX-101.LAB) — 33KB
- usaq-20240328_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this current report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: March 28, 2024 QHSLab, Inc. /s/ Troy Grogan Name: Troy Grogan Title: CEO and Chairman